Phraction Management LLC Buys 1,840 Shares of Danaher Corporation (NYSE:DHR)

Phraction Management LLC grew its position in Danaher Corporation (NYSE:DHR - Free Report) by 5.0% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 38,902 shares of the conglomerate's stock after purchasing an additional 1,840 shares during the period. Danaher comprises about 2.7% of Phraction Management LLC's portfolio, making the stock its 14th largest position. Phraction Management LLC's holdings in Danaher were worth $7,975,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Heck Capital Advisors LLC acquired a new stake in Danaher in the fourth quarter worth $27,000. GHP Investment Advisors Inc. raised its holdings in Danaher by 396.0% in the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after purchasing an additional 99 shares during the period. Hurley Capital LLC acquired a new stake in Danaher in the fourth quarter worth $34,000. Rialto Wealth Management LLC acquired a new stake in Danaher in the fourth quarter worth $34,000. Finally, Smallwood Wealth Investment Management LLC acquired a new stake in Danaher in the first quarter worth $31,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the stock. Wolfe Research dropped their price objective on shares of Danaher from $275.00 to $220.00 and set an "outperform" rating on the stock in a report on Monday, April 7th. TD Cowen raised their price objective on shares of Danaher from $240.00 to $248.00 and gave the stock a "buy" rating in a report on Wednesday, April 23rd. UBS Group dropped their price objective on shares of Danaher from $275.00 to $240.00 and set a "buy" rating on the stock in a report on Wednesday, April 23rd. HSBC lowered their price target on shares of Danaher from $270.00 to $240.00 in a research note on Friday, April 25th. Finally, Argus lowered their price target on shares of Danaher from $260.00 to $240.00 in a research note on Wednesday, April 23rd. Four investment analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $248.61.

Danaher Stock Performance

Shares of Danaher stock traded up $0.58 during trading on Friday, hitting $203.08. 1,390,744 shares of the stock were exchanged, compared to its average volume of 3,499,704. The stock has a market capitalization of $145.33 billion, a price-to-earnings ratio of 39.43, a price-to-earnings-growth ratio of 2.85 and a beta of 0.77. The company has a fifty day moving average price of $195.63 and a 200-day moving average price of $207.23. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $281.70. The company has a current ratio of 1.43, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.26. The company had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. Danaher had a net margin of 15.81% and a return on equity of 10.80%. As a group, equities analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.63%. Danaher's dividend payout ratio is presently 24.85%.

Insider Activity

In related news, Chairman Steven M. Rales sold 1,250,000 shares of Danaher stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the sale, the chairman owned 3,105,808 shares of the company's stock, valued at approximately $611,036,665.92. The trade was a 28.70% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Christopher Paul Riley sold 15,805 shares of Danaher stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the sale, the executive vice president directly owned 15,179 shares of the company's stock, valued at $3,005,442. The trade was a 51.01% decrease in their position. The disclosure for this sale can be found here. Insiders own 11.10% of the company's stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.